Kelly Price in

Kelly Price

Observer · DISC type ci
Managing Director US Rare Disease at ESTEVE
📍 United States

Kelly Price is the Managing Director of US Operations for ESTEVE, leveraging 28 years of pharmaceutical industry experience to build the companys first US affiliate. Her career highlights include transformative leadership in market access, patient-centric commercial strategies, and digital therapeutics. She holds a Bachelor of Science in Nursing from Baylor University.

Deeply committed to the rare disease community, Kelly actively champions patient stories and advocates for greater collaboration and courage in finding new treatments. She is passionate about supporting community organizations and celebrating the researchers and visionaries working to improve care for patients globally.

Her clinical background as a nurse provides her with a unique, patient-first perspective in her executive leadership roles within the pharmaceutical industry.

Read the full overview →
Experience
12 Years
Current Role
Managing Director US Rare Disease
Job Level
Mid-senior
Location
United States
Personality Overview

How Kelly shows up

Example Seeker
Curious
Assertive

They often ask many questions and rely heavily on information and documentation. They are generally good communicators and can be hard to convince. They can sound friendly and charming but can quickly change gears to become inquisitive and probing.

Priorities

Topics Kelly cares about

Rare Disease
Her current role as Managing Director at ESTEVE is focused on rare diseases, and she frequently posts about supporting the Adrenocortical Carcinoma (ACC) community.
Patient Advocacy
Actively shares patient stories on social media, emphasizing the importance of courage, collaboration, and learning from patient experiences to drive progress.
+4 more topics Login to view topics
Career

Work history

10-2022
Managing Director US Rare Disease
ESTEVE
2-2021 - 10-2022
VP Market Access
Mahana Therapeutics
1-2018 - 2-2021
Vice President, Patient and Market Access
Osmotica Pharmaceutical Corp.
6-2015 - 1-2018
President
Direct Success, Inc.
5-2013 - 5-2015
Director of Market Access and Pharmacy
Medimetriks Pharmaceuticals, Inc.
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1996 - 1998
Bachelor of Science in Nursing
Baylor University
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Kelly. Free, 10 seconds.